FORTREA HOLDINGS INC. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
FORTREA HOLDINGS INC. (FTRE) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-07-29
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-06-30 was $100.00K.
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-03-31 was $100.00K.
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-09-30 was $0.00.
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2025 was $300.00K, a 50.00% decline from fiscal 2024.
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was $600.00K.
- FORTREA HOLDINGS INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2023 was -$700.00K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-07-29 | $200.00K derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $100.00K 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $300.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | -$200.00K derived: sum of 3 quarters · filed 2026-07-29 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-11-05 | -$200.00K derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2025-03-31 | -$200.00K 10-Q · filed 2026-07-29 | |||
| 2024-12-31 | $600.00K 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$800.00K 10-Q · filed 2025-11-05 | -$700.00K derived: sum of 2 quarters · filed 2025-11-05 | -$200.00K derived: sum of 3 quarters · filed 2025-11-05 | -$1.30M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $100.00K 10-Q · filed 2025-11-05 | $600.00K derived: sum of 2 quarters · filed 2025-11-05 | -$500.00K derived: sum of 3 quarters · filed 2025-11-05 | -$100.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-03-31 | $500.00K 10-Q · filed 2025-11-05 | -$600.00K derived: sum of 2 quarters · filed 2025-11-05 | -$200.00K derived: sum of 3 quarters · filed 2025-11-05 | -$200.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2023-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$700.00K derived: sum of 2 quarters · filed 2025-03-03 | -$700.00K derived: sum of 3 quarters · filed 2025-03-03 | -$700.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-08 | $400.00K derived: sum of 2 quarters · filed 2024-11-08 | $400.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-11-08 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |